Search

Search Results

• Successful Treatment of Refractory Immune Thrombotic Thrombocytopenic Purpura with Daratumumab

  E.E. Klebanova, Gennadii Martinovich Galstyan, S.Yu. Mamleeva, D.K. Bessmertnyy, Z.T. Fidarova, E.N. Parovichnikova

  270-276

  01.07.2025

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure

  Ekaterina Alekseevna Karimova, E.I. Zhelnova, E.A. Baryakh, E.Yu. Grishina, E.N. Zotina, D.E. Gagloeva, V.N. Yakimets, O.L. Kochneva, E.N. Misyurina

  171-176

  01.04.2025

• Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials

  Margarita Andreevna Ulyanova, V.I. Vorobyev, L.A. Bychenkova, S.V. Semochkin

  145-152

  01.04.2025

• The Efficacy of Bortezomib, Lenalidomide, and Dexamethasone Combination as Induction Therapy in Patients with Multiple Myeloma Complicated by the End-Stage Renal Disease

  Sergei Vyacheslavovich Semochkin, E.I. Zhelnova, V.I. Kazey, A.V. Cherkasova, A.G. Nikiforova, N.F. Frolova, E.A. Baryakh, K.V. Yatskov, E.A. Karimova, O.N. Kotenko, E.N. Misyurina

  360-369

  01.10.2024

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• The Role of Autologous Hematopoietic Stem Cell Transplantation in the Therapy of Systemic AL Amyloidosis

  Olga Vladislavovna Pirogova, O.V. Kudyasheva, A.G. Smirnova, V.V. Porunova, S.V. Tolstova, K.R. Kalimulina, M.V. Chernous, Yu.Yu. Vlasova, I.S. Moiseev, V.A. Dobronravov, A.D. Kulagin

  128-136

  03.03.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

  Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova, E.A. Belyakova

  377-387

  01.10.2022

• Plasmablastic Lymphoma with Primary Impairment of Bone Marrow in a HIV-Negative Patient: A Literature Review and a Case Report

  Maiya Valerevna Firsova, M.V. Solov’ev, A.M. Kovrigina, L.P. Mendeleeva

  356-364

  01.10.2022

• Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

  Marina Olegovna Popova, I.V. Tsygankov, Ya.V. Gudozhnikova, Yu.A. Rogacheva, N.P. Volkov, K.V. Lepik, M.V. Demchenkova, M.V. Grigoreva, A.Yu. Efirkina, T.V. Shneider, Yu.V. Kopeikina, S.A. Stepanova, V.G. Potapenko, A.V. Klimovich, N.V. Medvedeva, M.A. Kolesnikova, T.I. Pospelova, N.B. Mikhailova, V.V. Baikov, A.D. Kulagin

  28-41

  01.01.2022

• Mantle Cell Lymphoma: History, Current Principles of Diagnosis, and Treatment (Literature Review)

  Gayane Sepugovna Tumyan

  366-381

  01.10.2020

• Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

  Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya

  25-32

  01.01.2020

• Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

  Anna Aleksandrovna Novikova, G.A. Klyasova, E.O. Gribanova, V.V. Ryzhko, T.A. Tupoleva, L.P. Mendeleeva, V.G. Savchenko

  231-239

  01.04.2019

• Practical Aspects of the Use of Carfilzomib in Multiple Myeloma

  Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev, K.D. Kaplanov

  21-31

  01.01.2019

• Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma

  Aleksandr Sergeevich Luchinin, S.V. Semochkin, N.V. Minaeva, N.M. Pozdeev, I.V. Paramonov

  175-181

  01.04.2018

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs

  Ol’ga Vladislavovna Pirogova, E.I. Darskaya, V.V. Porunova, O.V. Kudyasheva, A.G. Smirnova, I.S. Moiseev, E.V. Babenko, B.V. Afanas’ev

  187-191

  01.04.2018

• New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review

  Ol’ga Mikhailovna Votyakova

  425-434

  01.10.2017

• Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

  Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich

  381-389

  01.07.2017

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems

  L.R. Tilova, A.V. Savinkova, E.M. Zhidkova, O.I. Borisova, T.I. Fetisov, K.A. Kuzin, O.A. Vlasova, A.S. Antipova, O.Yu. Baranova, K.I. Kirsanov, G.A. Belitskii, M.G. Yakubovskaya, Ekaterina Andreevna Lesovaya

  235-249

  01.04.2017

• Elotuzumab for Treatment of Multiple Myeloma (Literature Review)

  Ol’ga Mikhailovna Votyakova

  438-445

  01.10.2016

• Pomalidomide for Treatment of Relapsed and Refractory Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  379-389

  01.10.2015

• Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

  T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva

  267-273

  01.07.2015

• Role of Bendamustine in Treatment of Multiple Myeloma

  O.M. Votyakova

  301-310

  01.07.2014

• Management of relapsed and refractory multiple myeloma: literature review and our data. Part III

  S.S. Bessmeltsev

  137-174

  01.04.2014

• Multiple myeloma (management of newly diagnosed patients): literature review and our on data. Part II

  S.S. Bessmeltsev

  379-414

  01.10.2013

• Current therapies for AL amyloidosis: literature review and our data

  A.G. Smirnova, S.N. Bondarenko, A.A. Kisina, A.V. Smirnov, A. Tsander, B.V. Afanasyev

  303-311

  01.07.2013